Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Human Genetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/301670PMID 9443863PMCID PMC1376797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

  1997cited by this paper
• Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

  1997cited by this paper
• A low proportion of BRCA2 mutations in Finnish breast cancer families.

  1997cited by this paper
• BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

  1997cited by this paper
• Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1996cited by this paper
• Genetic heterogeneity in breast cancer susceptibility.

  1996cited by this paper
• The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

  1996cited by this paper
• The genetics of breast and ovarian cancer.

  1995cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995influential reference
• A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

  1995cited by this paper
• Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

  1994cited by this paper
• A likelihood approach to calculating risk support intervals.

  1994cited by this paper
• Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.

  1993cited by this paper
• Pedigree Analysis for Genetic Counseling

  1992cited by this paper
• Evaluation of likelihood ratios for complex genetic models.

  1991cited by this paper
• Genetic analysis of breast cancer in the cancer and steroid hormone study.

  1991influential reference
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• Pedigree analysis in human genetics.

  1987cited by this paper
• Effect of age on incidence of breast cancer in females.

  1979cited by this paper
• The Application of Bayesian Methods in Genetic Counselling

  1969cited by this paper
• Medical genetics : advances in brief Population genetics of BRCA 1 and BRCA 2

  year unknowncited by this paper

• Variant‐Specific Mendelian Risk Prediction Model

  2025cites this paper
• Statistical algorithms for the analysis of deleterious genetic mutations

  2025cites this paper
• Associations of NPAR index with breast cancer incidence and mortality based on the National Health and Nutrition Examination Survey (NHANES) 2001-2018: a cross-sectional study.

  2025cites this paper
• Estrategia de Manejo y Prevención del Cáncer de Mama en Mujeres Posmenopáusicas con Sobrepeso u Obesidad: Un Enfoque Integral

  2025cites this paper
• Large-Scale Population Screening for BRCA1 and BRCA2 Ashkenazi Founder Mutations: Perspectives of Professionals Providing Oncogenetic Consultations

  2025cites this paper
• PERSONALIZED RISK PREDICTION FOR CANCER SURVIVORS: A GENERALIZED BAYESIAN SEMI-PARAMETRIC MODEL OF RECURRENT EVENTS WITH COMPETING OUTCOMES.

  2025cites this paper
• Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer

  2025cites this paper
• Current insights into breast and ovarian cancer risk: a contemporary review.

  2025cites this paper
• A Review of Current Breast Cancer Risk Calculators and Their Recent Advances

  2025cites this paper
• Update in the clinical utilization of chemoprevention for breast cancer: a narrative review

  2025cites this paper
• Screening in Women With BRCA Mutations Revisited.

  2024cites this paper
• Predicting the likelihood of BRCA1/2 germline pathogenic variants in unselected patients with breast cancer: analysis of more than 10,000 individuals

  2024cites this paper
• Germline variant profiling of CHEK2 sequencing variants in breast cancer patients.

  2024cites this paper
• A Retrospective Chart Analysis Comparing Breast Cancer Detection Rates Between Annual Versus Biennial Mammograms

  2024cites this paper
• Genetics of Breast Cancer

  2024cites this paper
• From pre-test and post-test probabilities to medical decision making

  2024cites this paper
• Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery

  2024cites this paper
• Predicting five-year interval second breast cancer risk in women with prior breast cancer.

  2024cites this paper
• Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.

  2024cites this paper
• From Pre-test and Post-test Probabilities to Medical Decision Making

  2024cites this paper
• LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations

  2024cites this paper
• Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic.

  2024cites this paper
• User Comprehension and EHR Integration of the RealRisks Decision Aid for Breast Cancer Risk Assessment: A Qualitative Study.

  2024cites this paper
• Breast cancer risk estimation with intelligent algorithms and risk factors for Cuban women

  2024cites this paper
• Artificial Intelligence for Breast Cancer Risk Assessment.

  2024cites this paper
• Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data

  2024cites this paper
• Next Top Model: An Overview of Breast Cancer Risk Assessment Models

  2024cites this paper
• Individualizing Breast Cancer Risk Assessment in Clinical Practice

  2024cites this paper
• Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.

  2024cites this paper
• Enhancing Breast Cancer Risk Prediction with Machine Learning: Integrating BMI, Smoking Habits, Hormonal Dynamics, and BRCA Gene Mutations—A Game-Changer Compared to Traditional Statistical Models?

  2024cites this paper
• Identifying the psychosocial barriers and facilitators associated with the uptake of genetic services for hereditary cancer syndromes: a systematic review of qualitative studies

  2024cites this paper
• Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk

  2023cites this paper
• Breast density analysis of digital breast tomosynthesis

  2023cites this paper
• Personalized Risk Prediction for Cancer Survivors: A Bayesian Semi-parametric Recurrent Event Model with Competing Outcomes

  2023cites this paper
• Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series

  2023cites this paper
• Clinical utility of polygenic risk scores: a critical 2023 appraisal

  2023cites this paper
• Implementing the National Dense Breast Reporting Standard, Expanding Supplemental Screening Using Current Guidelines, and the Proposed Find It Early Act.

  2023cites this paper
• Development of a breast cancer risk screening tool for women in Indonesia

  2023cites this paper
• The c.156_157insAlu rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal

  2023cites this paper
• Personalized Breast Cancer Screening

  2023cites this paper
• Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.

  2023cites this paper
• Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

  2023cites this paper
• Family history and breast cancer risk for Asian women: a systematic review and meta-analysis

  2023cites this paper
• Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute

  2023cites this paper
• Carrier screening program for BRCA1/BRCA2 pathogenic variants among Ashkenazi Jewish women in Israel: An observational study

  2023cites this paper
• Individualizing Breast Cancer Risk Assessment in Clinical Practice.

  2023cites this paper
• Breast Cancer Screening for Women at Higher-than-Average Risk: Updated Recommendations from the ACR.

  2023cites this paper
• Validation of an Abridged Breast Cancer Risk Prediction Model for the General Population

  2023cites this paper
• Variant-specific Mendelian Risk Prediction Model

  2023cites this paper
• Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma

  2023cites this paper
• Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study.

  2023cites this paper
• NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.

  2023cites this paper
• LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germline TP53 mutations

  2023cites this paper
• Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer

  2022cites this paper
• Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients

  2022cites this paper
• Genetics of Breast Cancer: Risk Models, Who to Test, and Management Options.

  2022cites this paper
• Klinische Evaluation des erblichen Krebsrisikos

  2022cites this paper
• The False Dawn of Polygenic Risk Scores for Human Disease Prediction

  2022cites this paper
• Optimal breast cancer risk reduction policies tailored to personal risk level

  2022cites this paper
• A bibliometric analysis of the top 100 most cited papers and research trends in breast cancer related BRCA1 and BRCA2 genes

  2022cites this paper
• Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment

  2022cites this paper
• Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic

  2022cites this paper
• Putting It All Together

  2022influential citation
• BREAST CANCER NATURAL HISTORY MODELS AND RISK PREDICTION IN MAMMOGRAPHY SCREENING COHORTS

  2022cites this paper
• The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients

  2022cites this paper
• Male Breast Cancer: From Molecular Genetics to Clinical Management

  2022cites this paper
• BRCA and Breast Cancer-Related High-Penetrance Genes.

  2021cites this paper
• Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.

  2021cites this paper
• Frequency of variants of hereditary cancer risk syndrome in 1682 Brazilian patients genotyped by next-generation sequencing

  2021cites this paper
• A simple framework to identify optimal cost‐effective risk thresholds for a single screen: Comparison to Decision Curve Analysis

  2021cites this paper
• Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors

  2021cites this paper
• Statistical methods for Mendelian models with multiple genes and cancers

  2021cites this paper
• A Review of Breast Cancer Risk Factors in Adolescents and Young Adults

  2021cites this paper
• Preventive population genomics: The model of BRCA related cancers.

  2021cites this paper
• Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

  2021cites this paper
• Screening and Preventative Strategies for Patients at High Risk for Breast Cancer.

  2021cites this paper
• Lack of Salivary Long Non-Coding RNA XIST Expression Is Associated with Increased Risk of Oral Squamous Cell Carcinoma: A Cross-Sectional Study

  2021cites this paper
• A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO

  2021cites this paper
• Present Options in the Prevention of Breast Cancer

  2021cites this paper
• Prediction of Hereditary Cancers Using Neural Networks

  2021cites this paper
• Utilization of breast cancer risk prediction models by cancer genetic counselors in clinical practice predominantly in the United States

  2021cites this paper
• Assessing Risk of Breast Cancer: A Review of Risk Prediction Models.

  2021cites this paper
• Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules

  2021cites this paper
• PANELPRO: A GENERAL FRAMEWORK FOR MULTI-GENE, MULTI-CANCER MENDELIAN RISK PREDICTION MODELS

  2021cites this paper
• miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil

  2020cites this paper
• Development of Breast Cancer Risk Prediction Model for Women in Indonesia: A Case-Control Study

  2020cites this paper
• Case Study: Uptake of Risk Appropriate Behaviors Following Breast Cancer Risk Stratification in the Mammography Screening Population

  2020cites this paper
• Oncology in the Precision Medicine Era: Value-Based Medicine

  2020cites this paper
• Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

  2020cites this paper
• A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome

  2020cites this paper
• Calculating, Using and Improving Individual Breast Cancer Risk Estimates

  2020cites this paper
• OP-JNCI190195 418..422

  2020cites this paper
• A likelihood‐based approach to assessing frequency of pathogenicity among variants of unknown significance in susceptibility genes

  2020cites this paper
• Breast cancer in global health: beyond diversity and inequality

  2020cites this paper
• Choosing Breast Cancer Risk Models: Importance of Independent Validation.

  2020cites this paper
• Number needed to test: quantifying risk stratification provided by diagnostic tests and risk predictions

  2020cites this paper
• New Approach for Risk Estimation Algorithms of BRCA1/2 Negativeness Detection with Modelling Supervised Machine Learning Techniques

  2020cites this paper
• Statistical approaches for meta‐analysis of genetic mutation prevalence

  2020cites this paper
• Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.

  2020cites this paper
• Germline testing for homologous recombination repair genes—opportunities and challenges

  2020cites this paper